Epidemiology and Prognosis of Multiple Myeloma
Ryan Haumschild, PharmD, MS, MBA, introduces the faculty and sets the agenda to explore disease background, novel therapies, and operational considerations in relapsed/refractory multiple myeloma.
Introduction and Pathophysiology of Multiple Myeloma